dc.contributor.author | Dangoor, A | |
dc.contributor.author | Joffe, J | |
dc.contributor.author | Januszewski, A | |
dc.contributor.author | Mansi, J | |
dc.contributor.author | Cunningham, D | |
dc.contributor.author | Selby, P | |
dc.contributor.author | 17 other authors and members of the Association of Cancer Physicians, UK | |
dc.date.accessioned | 2017-04-07T15:06:54Z | |
dc.date.issued | 2016-12-05 | |
dc.identifier.citation | BMJ (Clinical research ed.), 2016, 355 pp. i6487 - ? | |
dc.identifier.issn | 0959-8138 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/568 | |
dc.identifier.eissn | 1756-1833 | |
dc.identifier.doi | 10.1136/bmj.i6487 | |
dc.format | Electronic | |
dc.format.extent | i6487 - ? | |
dc.language | eng | |
dc.language.iso | eng | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | 17 other authors and members of the Association of Cancer Physicians, UK | |
dc.subject | Humans | |
dc.subject | Neoplasms | |
dc.subject | Antineoplastic Agents | |
dc.subject | Ethics | |
dc.subject | Codes of Ethics | |
dc.subject | Ethics, Medical | |
dc.subject | Physicians | |
dc.title | The Association of Cancer Physicians responds to "Cancer drugs, survival, and ethics". | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1136/bmj.i6487 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2016-12-05 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | BMJ (Clinical research ed.) | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.) | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.) | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 355 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Medicine (RMH Smith Cunningham) | en_US |
dc.contributor.icrauthor | Cunningham, David | en |